IDEAYA Biosciences (IDYA) Current Assets (2018 - 2026)

IDEAYA Biosciences has reported Current Assets for 9 years, with the latest figure at $696.1 million in Q1 2026.

• Quarterly Current Assets fell 1.66% year-over-year to $696.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $696.1 million (down 1.66% YoY) and the FY2025 annual result came in at $666.7 million, down 3.33% from the prior year.
• Current Assets rose to $696.1 million in Q1 2026 per IDYA's latest filing, from $666.7 million in the prior quarter.
• Over five years, Current Assets peaked at $932.2 million in Q3 2024 and troughed at $256.0 million in Q1 2022.
• A 5-year average of $573.9 million and a median of $666.7 million in 2025 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2024: Current Assets declined 16.91% in 2022, then jumped 106.23% in 2024.
• Over 5 years, Current Assets stood at $370.5 million in 2022, then jumped by 43.78% to $532.6 million in 2023, then grew by 29.49% to $689.7 million in 2024, then slipped by 3.33% to $666.7 million in 2025, then grew by 4.41% to $696.1 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $696.1 million, $666.7 million, and $802.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.